CUTISS
Developer of customized bio-engineered skin grafts designed to treat large skin defects. The company's customized skin grafts use patients' cells in combination with a hydrogel to create dermo-epiderm...
Valuation
$214.5M
Latest known
Share Price
N/A
Total Raised
$139.5M
Last Round
N/A